RAYE-ANNE AYO: Open Payments
NPI 1689699381 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 33 payments from 11 companies in 2025. Trend: 2023 $301 · 2024 $639 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Lilly USA, LLC | 2 | $37 |
| Amgen Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, MOUNJARO, OTEZLA, Sunosi, NEXLETOL, VRAYLAR.
Industry payments across TN — which companies pay providers there.
